Pfizer-BioNTech/Comirnaty, Moderna/Spikevax and Novavax/Nuvaxovid* are vaccines that are authorised by the Health Sciences Authority (HSA) for use in Singapore.

* Current stock of JN.1 Novavax/Nuvaxovid vaccine has expired since 31 May 2026 and no longer available under the NVP.

Under the NVP, vaccines authorised by the HSA for use in Singapore are free for all eligible Singaporean Citizens, Permanent Residents, Long Term Pass holders and certain Short Term Pass holders.